Prudential Financial
URGN icon

Prudential Financial’s UroGen Pharma URGN Stock Holding History

Prudential Financial’s Portfolio URGN Stock Details URGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$257K Buy
+6,975
New +$189K ﹤0.01% 2155
2024
Q4 		– Sell
-17,030
Closed -$216K – 2702
2024
Q3 		$216K Buy
+17,030
New +$253K ﹤0.01% 2496

Other funds holding URGN

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Prudential Financial's URGN Position: Q2 2026 in Review

Prudential Financial opened a new position in UroGen Pharma (URGN) in Q2 2026: 6,975 shares worth $257K. The stake represents ﹤0.01% of the portfolio and ranks #2155 among its holdings. This is a return to the name: Prudential Financial previously reported a position in URGN as recently as Q3 2024.

Prudential Financial first reported a position in URGN in Q3 2024 and has held it in 2 quarters since. 190 funds tracked by Wall St. Rank hold URGN as of Q2 2026.

  • Prudential Financial held 6,975 shares of UroGen Pharma worth $257K as of Q2 2026.
  • UroGen Pharma was a new Prudential Financial position in Q2 2026.
  • UroGen Pharma made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #2155 holding.
  • Prudential Financial first reported a position in UroGen Pharma in Q3 2024 and has held it in 2 quarters since.
  • 190 funds tracked by Wall St. Rank held UroGen Pharma as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.